Dm. Sahasrabudhe et Jc. Dusel, EFFECT OF MURINE INTERFERON-ALPHA BETA ON TUMOR-INDUCED SUPPRESSOR FUNCTION/, Cancer immunology and immunotherapy, 39(6), 1994, pp. 360-366
T-lymphocyte-mediated immunosuppression has been described in several
animal models and in man. In animal models, T-cell-mediated immunosupp
ression can hasten the development of cancers, permit the growth of tu
mors in immunocompetent hosts, and inhibit otherwise effective antitum
or immunotherapy. Cyclophosphamide can abrogate the T-cell-mediated im
munosuppression. However, inappropriately administered cyclophosphamid
e can adversely affect antitumor immunity. On the basis of data showin
g that interferon alpha/beta (IFN alpha/beta) and IFN beta selectively
abrogate the T-cell-mediated dinitrofluorobenzene-specific suppressor
function, we investigated the efficacy of purified murine IFN alpha/b
eta in manipulating tumor-induced T-cell-mediated immunosuppression in
the well-characterized P815 mastocytoma model. In this model, generat
ion of cytotoxicity in vitro and its inhibition by T cells correlates
with antitumor immunity in vivo. We report that IFN alpha/beta selecti
vely diminishes the generation of tumor-induced suppressor activity.